Strategic Hires The company has appointed a Chief Clinical Strategy Officer and a Chief Innovation Officer in recent years, signaling a focus on clinical integration, bedside imaging adoption, and innovation partnerships that can translate to early collaboration opportunities and pilot programs.

Clinical Expansion With intra-operative imaging and navigation aimed at neurosurgical procedures and a FDA 510(k) cleared SOLOPASS system, there are clear pathways to upsell adjunct devices, integration services, and training packages to hospitals and surgical centers expanding their neurosurgical capabilities.

Financial Footing Current revenue remains under one million, suggesting priority for strategic partnerships, channel alliances, and bundled offerings that align with hospital procurement cycles and grant-funded purchasing in medical device budgets.

Regulatory Milestones Historical FDA clearance activity demonstrates a track record of regulatory progress, enabling messaging around accelerated adoption timelines, post-market surveillance services, and reimbursement strategy support to prospective buyers.

Industry Positioning As a specialized medical device provider focused on bedside intra-operative imaging for neurosurgery, there are opportunities to position as a niche partner to large medical device firms seeking to augment their neurosurgical portfolio or co-development opportunities with bigger players.